quantitative
Analysis v1
Strong Support
People with heart disease who took a drug called evolocumab had more heart-related deaths than those who took a dummy pill, according to a reanalysis of a major study — but the difference wasn’t quite strong enough to rule out chance.
80
0
Evidence from Studies
Supporting (1)
80
Community contributions welcome
80
The study looked at the same drug and patients as the claim and found more heart-related deaths in the treatment group, just like the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.